Amgen Inc (AMGN)
294.53
+4.63
(+1.60%)
USD |
NASDAQ |
Nov 22, 16:00
294.53
0.00 (0.00%)
After-Hours: 20:00
Amgen Market Cap: 158.32B for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 158.32B |
| November 21, 2024 | 155.83B |
| November 20, 2024 | 154.74B |
| November 19, 2024 | 150.48B |
| November 18, 2024 | 149.84B |
| November 15, 2024 | 152.45B |
| November 14, 2024 | 159.07B |
| November 13, 2024 | 162.03B |
| November 12, 2024 | 160.64B |
| November 11, 2024 | 172.98B |
| November 08, 2024 | 174.85B |
| November 07, 2024 | 173.04B |
| November 06, 2024 | 172.97B |
| November 05, 2024 | 171.63B |
| November 04, 2024 | 170.35B |
| November 01, 2024 | 171.59B |
| October 31, 2024 | 172.10B |
| October 30, 2024 | 169.61B |
| October 29, 2024 | 169.86B |
| October 28, 2024 | 170.49B |
| October 25, 2024 | 170.39B |
| October 24, 2024 | 169.68B |
| October 23, 2024 | 169.26B |
| October 22, 2024 | 171.82B |
| October 21, 2024 | 170.25B |
| Date | Value |
|---|---|
| October 18, 2024 | 172.89B |
| October 17, 2024 | 172.71B |
| October 16, 2024 | 172.88B |
| October 15, 2024 | 174.74B |
| October 14, 2024 | 174.48B |
| October 11, 2024 | 176.49B |
| October 10, 2024 | 172.54B |
| October 09, 2024 | 173.30B |
| October 08, 2024 | 170.75B |
| October 07, 2024 | 170.63B |
| October 04, 2024 | 171.82B |
| October 03, 2024 | 170.65B |
| October 02, 2024 | 171.85B |
| October 01, 2024 | 172.17B |
| September 30, 2024 | 173.19B |
| September 27, 2024 | 173.38B |
| September 26, 2024 | 171.46B |
| September 25, 2024 | 168.11B |
| September 24, 2024 | 177.81B |
| September 23, 2024 | 180.33B |
| September 20, 2024 | 181.28B |
| September 19, 2024 | 180.52B |
| September 18, 2024 | 178.89B |
| September 17, 2024 | 178.82B |
| September 16, 2024 | 180.14B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
107.49B
Minimum
Mar 12 2020
181.28B
Maximum
Sep 20 2024
139.19B
Average
137.19B
Median
Market Cap Benchmarks
| Johnson & Johnson | 373.59B |
| Eli Lilly and Co | 710.10B |
| Merck & Co Inc | 250.89B |
| Regeneron Pharmaceuticals Inc | 81.10B |
| Viking Therapeutics Inc | 5.860B |
Market Cap Related Metrics
| PE Ratio | 37.71 |
| PS Ratio | 4.882 |
| Price to Book Value | 21.03 |
| Price to Free Cash Flow | 25.28 |
| Price | 294.53 |
| Earnings Yield | 2.65% |
| Operating PE Ratio | 25.54 |
| Normalized PE Ratio | 37.71 |